SSA
BNGO icon

Schonfeld Strategic Advisors’s Bionano Genomics BNGO Stock Holding History

Schonfeld Strategic Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-401
Closed -$147K – 1799
2023
Q2 		$147K Buy
+401
New +$181K ﹤0.01% 1648
2023
Q1 		– Sell
-23
Closed -$20.1K – 2123
2022
Q4 		$20.1K Buy
+23
New +$28.9K ﹤0.01% 2324
2022
Q3 		– Sell
-63
Closed -$52K – 2956
2022
Q2 		$52K Sell
63
-10
-14% -$10.3K ﹤0.01% 2217
2022
Q1 		$112K Buy
+73
New +$98.5K ﹤0.01% 2199
2021
Q3 		– Sell
-199
Closed -$877K – 2171
2021
Q2 		$877K Buy
+199
New +$786K 0.01% 970

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $2.19B AUM 72.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Schonfeld Strategic Advisors's BNGO Position: Q3 2023 in Review

Schonfeld Strategic Advisors sold out of Bionano Genomics (BNGO) in Q3 2023, closing a stake of 401 shares — an estimated $147K sold.

Schonfeld Strategic Advisors first reported a position in BNGO in Q2 2021 and held it in 5 quarters. The position peaked at $877K in Q2 2021. 46 funds tracked by Wall St. Rank hold BNGO as of Q3 2023.

  • Schonfeld Strategic Advisors reported no remaining Bionano Genomics position as of Q3 2023 after selling out during the quarter.
  • Schonfeld Strategic Advisors sold 401 Bionano Genomics shares in Q3 2023, an estimated $147K.
  • Schonfeld Strategic Advisors first reported a position in Bionano Genomics in Q2 2021 and held it in 5 quarters.
  • Schonfeld Strategic Advisors's Bionano Genomics position peaked at $877K in Q2 2021.
  • 46 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2023.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.